IT1134638B - Perfezionamenti apportati ai procedimenti di preparazione di forme galeniche ad azione ritardata e a liberazione programmata,e forme galeniche di medicamenti cosi' ottenute - Google Patents
Perfezionamenti apportati ai procedimenti di preparazione di forme galeniche ad azione ritardata e a liberazione programmata,e forme galeniche di medicamenti cosi' ottenuteInfo
- Publication number
- IT1134638B IT1134638B IT26515/80A IT2651580A IT1134638B IT 1134638 B IT1134638 B IT 1134638B IT 26515/80 A IT26515/80 A IT 26515/80A IT 2651580 A IT2651580 A IT 2651580A IT 1134638 B IT1134638 B IT 1134638B
- Authority
- IT
- Italy
- Prior art keywords
- galenic forms
- medicaments
- procedures
- preparation
- carried out
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7930085A FR2470599A1 (fr) | 1979-12-07 | 1979-12-07 | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8026515A0 IT8026515A0 (it) | 1980-12-09 |
IT1134638B true IT1134638B (it) | 1986-08-13 |
Family
ID=9232512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT26515/80A IT1134638B (it) | 1979-12-07 | 1980-12-09 | Perfezionamenti apportati ai procedimenti di preparazione di forme galeniche ad azione ritardata e a liberazione programmata,e forme galeniche di medicamenti cosi' ottenute |
Country Status (11)
Country | Link |
---|---|
US (1) | US5051262A (it) |
JP (1) | JPH0530804B2 (it) |
AT (1) | AT382513B (it) |
BE (1) | BE886510A (it) |
CH (1) | CH648207A5 (it) |
DE (1) | DE3050131T1 (it) |
ES (1) | ES8306322A1 (it) |
FR (1) | FR2470599A1 (it) |
GB (1) | GB2075343B (it) |
IT (1) | IT1134638B (it) |
WO (1) | WO1981001652A1 (it) |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4525345A (en) * | 1981-12-24 | 1985-06-25 | Verex Laboratories, Inc. | Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions |
FR2556964A1 (fr) * | 1983-12-23 | 1985-06-28 | Ile De France | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
US4752470A (en) * | 1986-11-24 | 1988-06-21 | Mehta Atul M | Controlled release indomethacin |
SE509029C2 (sv) * | 1988-08-16 | 1998-11-30 | Ss Pharmaceutical Co | Långtidsverkande diklofenak-natriumpreparat |
JP2514078B2 (ja) * | 1988-08-22 | 1996-07-10 | エスエス製薬株式会社 | 圧縮成型製剤 |
JPH03145418A (ja) * | 1989-10-27 | 1991-06-20 | Sumitomo Pharmaceut Co Ltd | 塩基性薬物塩酸塩の徐放性製剤 |
CH678920A5 (it) * | 1989-11-14 | 1991-11-29 | Gergely Gerhard | |
IT1246383B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per il mascheramento del sapore di farmaci |
US5288505A (en) * | 1991-06-26 | 1994-02-22 | Galephar P.R., Inc., Ltd. | Extended release form of diltiazem |
FI101039B (fi) * | 1992-10-09 | 1998-04-15 | Eeva Kristoffersson | Menetelmä lääkepellettien valmistamiseksi |
US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
US5484607A (en) * | 1993-10-13 | 1996-01-16 | Horacek; H. Joseph | Extended release clonidine formulation |
US5458887A (en) * | 1994-03-02 | 1995-10-17 | Andrx Pharmaceuticals, Inc. | Controlled release tablet formulation |
GB9407386D0 (en) | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
US20030109503A1 (en) * | 1995-06-06 | 2003-06-12 | Smithkline Beecham P.L.C. | Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics |
US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
US5830503A (en) * | 1996-06-21 | 1998-11-03 | Andrx Pharmaceuticals, Inc. | Enteric coated diltiazem once-a-day formulation |
ATE197900T1 (de) * | 1996-08-15 | 2000-12-15 | Losan Pharma Gmbh | Gut schluckbare orale arzneiform |
US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
US20030124187A1 (en) * | 1997-02-14 | 2003-07-03 | Smithkline Beecham Laboratoires Pharmaceutiques, | Pharmaceutical formulations comprising amoxycillin and clavulanate |
IN186245B (it) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
US5948440A (en) * | 1997-12-17 | 1999-09-07 | Ranbaxy Laboratories Limited | Modified release matrix formulation of cefaclor and cephalexin |
DE19845358A1 (de) * | 1998-10-02 | 2000-04-06 | Roehm Gmbh | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
US20010055613A1 (en) | 1998-10-21 | 2001-12-27 | Beth A. Burnside | Oral pulsed dose drug delivery system |
US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
US7250176B1 (en) * | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
ITMI20000788A1 (it) * | 1999-04-13 | 2001-10-11 | Beecham Pharmaceuticals Pte Li | Nuovo metodo di trattamento |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
CA2352211C (en) * | 1999-09-30 | 2009-03-24 | Edward Mendell Co., Inc. | Sustained release matrix systems for highly soluble drugs |
US7108866B1 (en) | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
US20060153914A1 (en) * | 1999-12-10 | 2006-07-13 | Biovail Laboratories International S.R.L. | Chronotherapeutic diltiazem formulations and the administration thereof |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6476006B2 (en) | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
US7674480B2 (en) * | 2000-06-23 | 2010-03-09 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
US6881420B2 (en) | 2000-06-23 | 2005-04-19 | Teva Pharmaceutical Industries Ltd. | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation |
DE10031043A1 (de) | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
AU2001292185A1 (en) | 2000-10-12 | 2002-04-22 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
PL370764A1 (en) * | 2001-10-05 | 2005-05-30 | Combinatorx, Incorporated | Combinations for the treatment of immunoinflammatory disorders |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
DE10209982A1 (de) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma | Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe |
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
US6958161B2 (en) | 2002-04-12 | 2005-10-25 | F H Faulding & Co Limited | Modified release coated drug preparation |
US6913768B2 (en) * | 2002-09-24 | 2005-07-05 | Shire Laboratories, Inc. | Sustained release delivery of amphetamine salts |
EP1648418A4 (en) | 2003-07-21 | 2011-11-16 | Middlebrook Pharmaceuticals Inc | ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION |
AU2004258949B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
CA2533292C (en) | 2003-07-21 | 2013-12-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
CA2535177A1 (en) | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
EP1653924A4 (en) | 2003-08-12 | 2009-09-09 | Middlebrook Pharmaceuticals In | ANTIBIOTICS, USE AND FORMULATION ASSOCIATED |
CA2535780A1 (en) * | 2003-08-29 | 2005-03-17 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
US8460710B2 (en) | 2003-09-15 | 2013-06-11 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
TW200517114A (en) * | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
UY28583A1 (es) * | 2003-10-30 | 2005-05-31 | Roche Consumer Health Ag | Forma de presentación del naproxeno sodico |
CA2572292A1 (en) | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
CN1993112A (zh) * | 2004-07-29 | 2007-07-04 | 赛诺菲-安万特 | 用于具有高度pH依赖性溶解度的活性成分的控释的药物多层片剂 |
US20070087056A1 (en) * | 2005-08-09 | 2007-04-19 | Claudia Guthmann | Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility |
GB0517204D0 (en) * | 2005-08-22 | 2005-09-28 | Novartis Ag | Organic compounds |
CN102198273A (zh) * | 2005-08-22 | 2011-09-28 | 诺瓦提斯公司 | 包含pH依赖性药物、pH调节剂和阻滞剂的药物组合物 |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8299052B2 (en) * | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
CA2652773A1 (en) * | 2006-05-22 | 2007-12-06 | Combinatorx, Incorporated | Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels |
US20070292503A1 (en) * | 2006-06-16 | 2007-12-20 | Gorissen Henricus R | Oral pharmaceutical composition of poorly water-soluble active substance |
EP1958615A1 (en) * | 2007-02-13 | 2008-08-20 | Bayer Schering Pharma Aktiengesellschaft | Solid pharmaceutical formulations of a homogeneous dispersion of active principles having pH-dependent solubility |
MX2009013384A (es) * | 2007-06-08 | 2010-01-25 | Addrenex Pharmaceuticals Inc | Formulacion de liberacion extendida, y metodo para tratar disregulacion adrenergica. |
US20100172991A1 (en) * | 2007-06-08 | 2010-07-08 | Henry Joseph Horacek | Extended Release Formulation and Methods of Treating Adrenergic Dysregulation |
WO2009038708A1 (en) * | 2007-09-19 | 2009-03-26 | Combinatorx, Incorporated | Therapeutic regimens for the treatment of immunoinflammatory disorders |
KR20100121601A (ko) * | 2007-12-17 | 2010-11-18 | 콤비네이토릭스, 인코포레이티드 | 면역염증성 질환의 치료를 위한 치료요법 |
WO2009085306A1 (en) | 2007-12-28 | 2009-07-09 | Impax Laboratories, Inc. | Controlled release formulations of levodopa and uses thereof |
AU2009290712A1 (en) | 2008-09-09 | 2010-03-18 | Astrazeneca Ab | Method for delivering a pharmaceutical composition to patient in need thereof |
WO2010151216A1 (en) | 2009-06-25 | 2010-12-29 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
US9011912B2 (en) | 2010-10-07 | 2015-04-21 | Abon Pharmaceuticals, Llc | Extended-release oral dosage forms for poorly soluble amine drugs |
JP2014513710A (ja) * | 2011-05-20 | 2014-06-05 | アバンテイス・フアルマ・エス・アー | ケトプロフェンを含む医薬組成物 |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
CA2860231A1 (en) | 2011-12-28 | 2013-07-04 | Pozen Inc. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
AU2013235266B2 (en) | 2012-03-20 | 2017-10-19 | Particle Dynamics International, Llc | Gelling agent-based dosage form |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
EP3782614A1 (en) | 2013-10-07 | 2021-02-24 | Impax Laboratories, LLC | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
EP3125873B1 (en) | 2014-04-04 | 2020-06-03 | Pharmaquest International Center, LLC | Disintegrating monolithic modified release tablets containing quadri-layer extended release granules |
CA2936741C (en) | 2014-10-31 | 2018-11-06 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US443428A (en) * | 1890-12-23 | Drinking-fountain for poultry | ||
GB862376A (en) * | 1957-10-10 | 1961-03-08 | Pfizer & Co C | Sustained release pharmaceutical tablet |
US2993836A (en) * | 1958-02-20 | 1961-07-25 | Dow Chemical Co | Sustained release tablets |
US2971889A (en) * | 1958-03-18 | 1961-02-14 | Smith Kline French Lab | Press coated enteric tablets and process for preparing them |
US3136692A (en) * | 1961-06-30 | 1964-06-09 | Strong Cobb Arner Inc | Effervescent composition containing polyvinylpyrrolidone |
US3247066A (en) * | 1962-09-12 | 1966-04-19 | Parke Davis & Co | Controlled release dosage form containing water-swellable beadlet |
US3330729A (en) * | 1963-10-04 | 1967-07-11 | Goodrich Co B F | Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent |
GB1139991A (en) * | 1965-07-19 | 1969-01-15 | Armour Pharma | Stabilized enzyme composition |
CH434571A (de) * | 1966-07-05 | 1967-04-30 | Chemical And Pharmaceutical Pa | Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung |
GB1139869A (en) * | 1966-01-06 | 1969-01-15 | Moore Medicinal Products Ltd | Improvements in or relating to tablets |
FR7392M (it) * | 1966-07-19 | 1969-11-03 | ||
AT270071B (de) * | 1966-08-12 | 1969-04-10 | Roehm & Haas Gmbh | Dragierlack für Arzneiformen |
US3634584A (en) * | 1969-02-13 | 1972-01-11 | American Home Prod | Sustained action dosage form |
US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
US3557279A (en) * | 1969-06-12 | 1971-01-19 | Merck & Co Inc | Microencapsulation form of an anti-inflammatory drug |
US3608063A (en) * | 1969-08-15 | 1971-09-21 | Gilbert S Banker | Molecular drug entrapment process and compositions |
US3629393A (en) * | 1969-09-11 | 1971-12-21 | Nikken Chemicals Co Ltd | Release-sustaining-tablet |
BE759520A (fr) * | 1969-11-28 | 1971-04-30 | Aspro Nicholas Ltd | Compositions d'aspirine |
DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
US3653914A (en) * | 1970-03-20 | 1972-04-04 | Alberto Culver Co | Production of tablets |
US3764668A (en) * | 1970-09-30 | 1973-10-09 | Interx Research Corp | Compositions of salts of salicylamide |
US3676549A (en) * | 1970-09-30 | 1972-07-11 | Alza Corp | Administration of alkali metal salts of salicylamide |
US3885027A (en) * | 1971-04-12 | 1975-05-20 | West Laboratories Inc | Orally administered drug composition for therapy in the treatment of narcotic drug addiction |
NL7314765A (it) * | 1972-10-31 | 1974-05-02 | ||
US3954959A (en) * | 1973-03-28 | 1976-05-04 | A/S Alfred Benzon | Oral drug preparations |
GB1468172A (en) * | 1973-03-28 | 1977-03-23 | Benzon As Alfred | Oral drug preparations |
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
JPS5157813A (en) * | 1974-11-14 | 1976-05-20 | Sankyo Co | Ll dooba mataha sonojudotaiseizaino seiho |
NZ179623A (en) * | 1975-01-06 | 1978-03-06 | Ciba Geigy | Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund |
GB1509866A (en) * | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
FR2353285A1 (fr) * | 1975-09-17 | 1977-12-30 | Doms Laboratoires | Medicament vasodilatateur coronarien perfectionne |
SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
HU174057B (hu) * | 1976-09-17 | 1979-10-28 | Richter Gedeon Vegyeszet | Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva |
LU77353A1 (it) * | 1977-05-16 | 1979-01-19 | ||
DE2735830A1 (de) * | 1977-08-09 | 1979-03-01 | Thomae Gmbh Dr K | Antithrombotische arzneimittelkombination und verfahren zu ihrer herstellung |
US4196187A (en) * | 1977-09-02 | 1980-04-01 | Eastman Kodak Company | Rumen-stable pellets |
US4181708A (en) * | 1977-09-02 | 1980-01-01 | Eastman Kodak Company | Rumen-stable pellets |
FR2401619A1 (fr) * | 1977-09-02 | 1979-03-30 | Eastman Kodak Co | Procede pour preparer des granules indegradables dans la panse des ruminants |
GB1594102A (en) * | 1977-09-26 | 1981-07-30 | Sankyo Co | Ingestible coating compositions |
US4180559A (en) * | 1978-01-05 | 1979-12-25 | Richardson-Merrell Inc. | Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions |
HU179474B (en) * | 1978-02-24 | 1982-10-28 | Laszlo Gyarmati | Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material |
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
US4248872A (en) * | 1978-09-01 | 1981-02-03 | Horrobin David F | Method for the treatment of anxiety |
US4341563A (en) * | 1978-11-17 | 1982-07-27 | Sankyo Company Limited | Protective coating compositions |
US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
DE2950977A1 (de) * | 1978-12-22 | 1980-07-10 | Donald E Panoz | Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung |
US4261969A (en) * | 1979-05-03 | 1981-04-14 | World Health Organization | Controlled drug release composition |
US4289751A (en) * | 1979-06-29 | 1981-09-15 | Merck & Co., Inc. | Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof |
DE3000979A1 (de) * | 1980-01-12 | 1981-07-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue dipyridamol-retardformen und verfahren zu ihrer herstellung |
IT1148784B (it) * | 1980-04-09 | 1986-12-03 | Eurand Spa | Procedimento per la preparazione di microcapsule in un veicolo liquido |
US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4344929A (en) * | 1980-04-25 | 1982-08-17 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
HU183408B (en) * | 1981-04-28 | 1984-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing oral ratard pharmaceutical compositions |
DE3124090A1 (de) * | 1981-06-19 | 1983-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale dipyridamolformen |
DK150008C (da) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
BG36086A1 (en) * | 1982-01-19 | 1984-09-14 | Glbov | Method for inducing interferon |
JPS58134019A (ja) * | 1982-02-05 | 1983-08-10 | Ono Pharmaceut Co Ltd | プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法 |
US4432965A (en) * | 1982-07-09 | 1984-02-21 | Key Pharmaceuticals, Inc. | Quinidine sustained release dosage formulation |
DK152744C (da) * | 1982-08-13 | 1988-10-31 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat |
DK151608C (da) * | 1982-08-13 | 1988-06-20 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse |
US4521401A (en) * | 1983-01-03 | 1985-06-04 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of quinidine |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
IE56459B1 (en) * | 1983-12-21 | 1991-08-14 | Elan Corp Ltd | Controlled absorption pharmaceutical formulation |
IE56999B1 (en) * | 1983-12-22 | 1992-03-11 | Elan Corp Plc | Pharmaceutical formulation |
DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
DE3586600T2 (de) * | 1984-02-10 | 1993-02-18 | Benzon Pharma As | Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend. |
-
1979
- 1979-12-07 FR FR7930085A patent/FR2470599A1/fr active Granted
-
1980
- 1980-12-05 BE BE1/10060A patent/BE886510A/fr not_active IP Right Cessation
- 1980-12-05 DE DE803050131T patent/DE3050131T1/de active Granted
- 1980-12-05 CH CH5027/81A patent/CH648207A5/fr not_active IP Right Cessation
- 1980-12-05 GB GB8122407A patent/GB2075343B/en not_active Expired
- 1980-12-05 WO PCT/FR1980/000176 patent/WO1981001652A1/fr active Application Filing
- 1980-12-05 AT AT0912580A patent/AT382513B/de not_active IP Right Cessation
- 1980-12-05 JP JP56500111A patent/JPH0530804B2/ja not_active Expired - Lifetime
- 1980-12-06 ES ES497534A patent/ES8306322A1/es not_active Expired
- 1980-12-09 IT IT26515/80A patent/IT1134638B/it active
-
1986
- 1986-11-18 US US06/933,287 patent/US5051262A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GB2075343A (en) | 1981-11-18 |
BE886510A (fr) | 1981-06-05 |
IT8026515A0 (it) | 1980-12-09 |
WO1981001652A1 (fr) | 1981-06-25 |
GB2075343B (en) | 1984-10-10 |
CH648207A5 (fr) | 1985-03-15 |
ES497534A0 (es) | 1983-05-16 |
FR2470599A1 (fr) | 1981-06-12 |
US5051262A (en) | 1991-09-24 |
AT382513B (de) | 1987-03-10 |
FR2470599B1 (it) | 1983-03-25 |
JPH0530804B2 (it) | 1993-05-11 |
DE3050131T1 (de) | 1982-03-25 |
ATA912580A (de) | 1986-08-15 |
JPS56501803A (it) | 1981-12-10 |
DE3050131C2 (it) | 1992-01-09 |
ES8306322A1 (es) | 1983-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1134638B (it) | Perfezionamenti apportati ai procedimenti di preparazione di forme galeniche ad azione ritardata e a liberazione programmata,e forme galeniche di medicamenti cosi' ottenute | |
ATA195588A (de) | Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu | |
EG15011A (en) | Optically active 1,4-dihydropyridines,process for their preparation and their use as medicaments | |
ITMI911953A0 (it) | Procedimento di preparazione di composizione a cessione protratta e le composizioni cosi' ottenute | |
IT8022327A0 (it) | Metodo per la produzione di una cinghia articolata ed una cinghia articolata cosi' prodotta. | |
NO802843L (no) | Fremgangsmaate for fremstilling av aktivt karbon i fibroes form | |
IT8050124A0 (it) | Perfezionamento nelle spolette di prossimita' | |
IT8048968A0 (it) | Composti 2,4-diamminopirido (2,3-d)pirimidinici dotati di attivita'farmacologica e procedimento per laloro preparazione | |
IT1225474B (it) | Procedimento per la preparazione di compresse solubili e/o divisibili e compresse cosi' ottenute. | |
TR20746A (tr) | Homoserin tuerevleri,bunlarin hazirlanisi icin usul ve bunlarin mikrobisidler olarak kullanilmalari | |
IT8047899A0 (it) | Procedimento per preparare sodio cefurossima e prodotto ottenuto in forma di solvato | |
IT1227447B (it) | Procedimento per preparare polinucleotidi, prodotto cosi'ottenuto e preparazioni farmaceutiche contenenti il medesimo | |
HUT43315A (en) | Herbicidal composition comprising 2-aryl-4,5,6,7-tetrahydro-isoindoline derivatives as active substance and process for preparing the active substance | |
PH25388A (en) | 2-(PERHYDRO-1,4-DIAZINO)-PYRIMIDO-£5,4-d|-PYRIMIDINES, SALTS THEREOF | |
NZ185908A (en) | 1,2-disubstituted-1,2,4-triazolidine-3,5-diones and pharmaceutical compositions | |
HUT60711A (en) | Process for producing new crystalline (s)-norfluoxetine and pharmaceutical composition comprising the active ingredient | |
HUT57547A (en) | Herbicidal compositions comprising n-phenylsulfonyl-n'-pyrimidinyl-urea derivatives as active ingredient and process for producing the active ingredient | |
IT7950306A0 (it) | Procedimento per preparare composti di cefalosporina e composti cosi'ottenuti | |
IT8383505A0 (it) | Perfezionate. perfezionamenti alle raddrizzatrici e raddrizzatrici cosi' | |
IT9021905A0 (it) | Procedimento per la produzione di manufatti fosforescenti e manufatti cosi' ottenuti | |
IT1145339B (it) | Acidi-6ammino-spiro(penam-2,4'-piperidino)-3-carbossilici e loro procedimento di preparazione | |
IT8319966A0 (it) | Componente per la costruzione di un impianto di riscaldamento ed impianto di riscaldamento cosi'costruito. | |
SE8003656L (sv) | Estreno(2,3-d)-dihydroisoxazoldioler och framstellning derav | |
ES264458Y (es) | "trituradora desbrozadora perfeccionada". | |
IT8947738A0 (it) | Procedimento per produrre poliesteralcoli e composizioni cosi' ottenuti |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19971223 |